DLB Dolby Laboratories, Inc.
Patent Owners & Lessors · NYSE · SEC CIK 1308547 · Fiscal year ends 09/27
Financial factors as of 2026-09-25 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.3%
TTM net income YoY1.1%
TTM EPS YoY3.1%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR8.7%
Margins
Gross margin86.9%
Operating margin21.4%
Net margin18.1%
FCF margin25.3%
EBITDA margin28.1%
Returns
ROE9.9%
ROA8.1%
ROIC (approx.)12.0%
Asset turnover0.44x
Leverage & solvency
Liabilities / assets17.5%
Debt / equity0.00x
Current ratio3.18x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.55x
Accruals ratio-4.4%
Payout ratio52.9%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-09-25 | FY20252025-09-26 |
|---|---|---|
| Income statement | ||
| Revenue | $1.42B | $1.35B |
| Cost of revenue | $186.50M | $160.13M |
| Gross profit | $1.23B | $1.19B |
| R&D expense | $262.78M | $261.79M |
| SG&A expense | $301.59M | $286.53M |
| Operating income | $303.99M | $264.96M |
| Pretax income | $337.38M | $303.49M |
| Income tax | $77.86M | $46.99M |
| Net income | $257.74M | $255.02M |
| EBITDA | $399.00M | $352.79M |
| EPS (basic) | 2.73 | 2.66 |
| EPS (diluted) | 2.70 | 2.62 |
| Dividends declared per share | 1.44 | 1.32 |
| Weighted avg. shares (diluted) | 95.59M | 97.48M |
| Banking | ||
| Net interest income | $16.67M | $15.38M |
| Balance sheet | ||
| Cash & equivalents | $622.88M | $701.89M |
| Short-term investments | $500,000 | $703,000 |
| Receivables | $301.08M | $331.10M |
| Inventory | $28.45M | $30.42M |
| Current assets | $1.33B | $1.39B |
| PP&E, net | $457.35M | $470.61M |
| Goodwill | $529.06M | $529.90M |
| Intangibles | $389.41M | $397.06M |
| Total assets | $3.17B | $3.23B |
| Current liabilities | $417.81M | $437.79M |
| Total liabilities | $556.01M | $595.81M |
| Shareholders' equity | $2.60B | $2.62B |
| Cash flow statement | ||
| Operating cash flow | $399.55M | $472.20M |
| Capital expenditure | $39.63M | $36.35M |
| Free cash flow | $359.91M | $435.85M |
| Investing cash flow | -$84.18M | -$10.59M |
| Financing cash flow | -$410.89M | -$247.24M |
| Depreciation & amortization | $95.00M | $87.83M |
| Stock-based compensation | $133.29M | $128.51M |
| Dividends paid | $136.32M | $126.60M |
| Share buybacks | $265.00M | $124.99M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.